substance p has been researched along with rupatadine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chliva, C; Clemons, A; House, M; Kalogeromitros, D; Kempuraj, D; Makris, M; Theoharides, TC; Vasiadi, M; Wolfberg, A; Zhang, B | 1 |
| Alevizos, M; Kalogeromitros, D; Karagkouni, A; Makris, M; Sismanopoulos, N; Theoharides, TC; Vasiadi, M | 1 |
| Theoharides, TC | 1 |
3 other study(ies) available for substance p and rupatadine
| Article | Year |
|---|---|
Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
Topics: Antibodies, Anti-Idiotypic; Cell Line, Tumor; Cells, Cultured; Cyproheptadine; Cytokines; Histamine; Histamine H1 Antagonists; Humans; Interleukin-1; Interleukin-4; Interleukin-6; Mast Cells; Stem Cell Factor; Substance P; Vascular Endothelial Growth Factor A | 2010 |
Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor.
Topics: Anti-Allergic Agents; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cyproheptadine; Histamine; Humans; Interleukin-8; Mast Cells; Platelet Activating Factor; Substance P; Tumor Necrosis Factor-alpha | 2013 |
Potential association of mast cells with coronavirus disease 2019.
Topics: Cell Communication; Cholecalciferol; COVID-19; COVID-19 Drug Treatment; Cromolyn Sodium; Cyproheptadine; Cytokines; Famotidine; Histamine; Histamine Antagonists; Humans; Lung; Luteolin; Macrophages; Mast Cells; SARS-CoV-2; Severity of Illness Index; Substance P | 2021 |